Validity of self-administered symptom scales in clients with schizophrenia and schizoaffective disorders

https://doi.org/10.1016/0920-9964(95)00100-XGet rights and content

Abstract

Few studies have used self-administered symptom scales as outcome measures with individuals who have schizophrenia. However, with the increase in community-based treatment for the serious and persistently mentally ill and the emphasis on client empowerment, their ability to monitor and report symptoms needs to be assessed. Two forms of self-administered items, symptom distress statements and symptom intensity statements, were formed from 10 BPRS symptoms and administered to 29 individuals with schizophrenia. Both forms of self-administered items were highly correlated with BPRS items, supporting concurrent validity. Self-administered responses for positive symptoms of schizophrenia and nonpsychotic symptoms may be more valid than self-administered responses for negative or deficit symptoms.

References (15)

There are more references available in the full text version of this article.

Cited by (48)

  • Comparison of self-report and clinician-rated schizotypal traits in schizotypal personality disorder and community controls

    2019, Schizophrenia Research
    Citation Excerpt :

    In support of our hypothesis, SPQ subscale scores were significantly associated with their corresponding clinician-rated SIDP item scores for cognitive-perceptual (positive) schizotypal traits in both groups. This result is consistent with studies in schizophrenia suggesting that self-reported positive symptoms corresponded well with clinician ratings (Hamera et al., 1996; Lincoln et al., 2010; Liraud et al., 2004), although some studies have failed to find such correlations for positive symptoms (Biancosino et al., 2007; Morlan and Tan, 1998). Positive schizotypal traits may be more accurately self-reported as the SPQ asks about these items directly (e.g., “Do you sometimes feel that things you see on the TV or read in the newspaper have a special meaning for you?”),

  • Patient versus rater evaluation of symptom severity in treatment resistant schizophrenia receiving clozapine

    2019, Psychiatry Research
    Citation Excerpt :

    Instead, our findings demonstrated a modest, but significant, correlation; it is also worth pointing out that they employed the BPRS (Hamera et al., 1996). We do agree with their argument that patients may find it more difficult to self-rate negative symptoms due to the behavioral, versus experiential, nature of negative symptoms (Hamera et al., 1996). As with others, we too found that age and gender did not seem to impact scores (Bradshaw and Brekke, 1999).

View all citing articles on Scopus
View full text